Linoseptic (Octenidine Dihydrochloride, Phenoxyethanol)

Octenidine Dihydrochloride disrupts the integrity of bacterial cell membranes, causing rapid loss of cellular contents and death. This membrane‑active mechanism provides fast‑acting, broad‑spectrum activity against Gram‑positive and Gram‑negative bacteria when applied to the skin.

The amount of Linoseptic to apply is determined by the prescribing healthcare professional. Typically, a thin layer is spread over the intended skin area, but the exact volume and frequency depend on the specific clinical situation and the prescriber's instructions.

Safety data for Linoseptic in pregnancy and lactation are limited. The product’s pregnancy category is unknown, so it should only be used if the potential benefit justifies any possible risk. Consultation with a qualified healthcare provider is essential before use.

To order Linoseptic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both Linoseptic and chlorhexidine are topical antiseptics, but Linoseptic contains octenidine, which has a different membrane‑disrupting mechanism and is less likely to cause staining. Chlorhexidine may have a longer residual effect, whereas octenidine offers rapid bactericidal activity with a favorable safety profile for many skin applications.

Linoseptic should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from moisture, direct sunlight and extreme temperatures. Keep the container tightly closed when not in use to maintain stability and prevent contamination.

Linoseptic is applied topically to clean, dry skin. A thin, even layer should be spread over the target area using a sterile gauze or applicator. Allow the solution to air‑dry before covering the site or proceeding with any invasive procedure, unless otherwise directed by a clinician.

The most serious risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, and extensive skin necrosis, although these events are rare. Immediate medical attention is required if signs of systemic allergy, blistering, or rapidly spreading skin damage occur after application.

Linoseptic should not be used on patients with known hypersensitivity to octenidine, phenoxyethanol, or any of the product’s excipients. It is also contraindicated on large areas of severely damaged skin, mucous membranes, and in individuals where a severe allergic reaction to similar antiseptics has been documented.